Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis
Status:
Enrolling by invitation
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare the efficacy and safety of Topiramate,
Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis in outddor migraine
patients attending headache clinic. The main question it aims to answer is whether there is
any difference between the efficacy of Topiramate, Amitriptyline monotherapy and combination
therapy in migraine prophylaxis. Participants will take Topiramate, Amitriptyline Monotherapy
and Combination Therapy and maintain a headache diary. Researchers will compare Topiramate,
Amitriptyline Monotherapy and Combination Therapy groups to see if there is any differences
in efficacy and safety.